Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Baird

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease PatientsLauren M Curtis, Filip Pirsl, Seth M Steinberg, et al.
Hemasphere|June 24, 2022
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host DiseaseAna Zelic Kerep, Filip Pirsl, Seth Steinberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2015
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host diseaseKristin Baird, Leora E Comis, Galen O Joe, et al.
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Transplantation and Cellular Therapy|February 3, 2022
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome PathogenesisKirsten M Williams, Steven Z Pavletic, Stephanie J Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2016
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host DiseaseFrances T Hakim, Sarfraz Memon, Ping Jin, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Transplantation and Cellular Therapy|May 9, 2021
Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 DeficiencyMark Parta, Kristen Cole, Daniele Avila, et al.
Bone Marrow Transplantation|August 10, 2018
Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patientsAna Zelic Kerep, Jacob Broome, Filip Pirsl, et al.
Blood|September 25, 2020
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host diseaseLauren M Curtis, Alen Ostojic, David J Venzon, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease PatientsLauren M Curtis, Filip Pirsl, Seth M Steinberg, et al.
Hemasphere|June 24, 2022
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host DiseaseAna Zelic Kerep, Filip Pirsl, Seth Steinberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2015
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host diseaseKristin Baird, Leora E Comis, Galen O Joe, et al.
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Transplantation and Cellular Therapy|February 3, 2022
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome PathogenesisKirsten M Williams, Steven Z Pavletic, Stephanie J Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2016
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host DiseaseFrances T Hakim, Sarfraz Memon, Ping Jin, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Transplantation and Cellular Therapy|May 9, 2021
Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 DeficiencyMark Parta, Kristen Cole, Daniele Avila, et al.
Bone Marrow Transplantation|August 10, 2018
Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patientsAna Zelic Kerep, Jacob Broome, Filip Pirsl, et al.
Blood|September 25, 2020
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host diseaseLauren M Curtis, Alen Ostojic, David J Venzon, et al.
Pageof 6